—#147582

Product

Target Detachable Coils: TARGET HELICAL NANO 2MM X 6CM MODEL Number:M0035452060 Neurology: Target Detachable Coils are intended to endovascularly obstruct or occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels.

FDA product code: HCG — Device, Neurovascular Embolization
Device class: Class 2
Medical specialty: Neurology
510(k) numbers: K113412, K153658
Affected lot / code info: MODEL Number:M0035452060; Lot Number/Expiration Date: 18777380 31-Dec-18 18538894 31-Aug-18 18726354 30-Nov-18 18830541 31-Jan-19 18802659 31-Jan-19 18776332 31-Dec-18 18499021 31-Jul-18 18743910 30-Nov-18 18725944 30-Nov-18 18454649 30-Jun-18 18794568 31-Jan-19 18538832 31-Aug-18 18829512 31-Jan-19 18801344 31-Jan-19 18709049 30-Nov-18 18693095 30-Nov-18 18499207 31-Jul-18 19032899 30-Apr-19 19047487 31-May-19 18852469 28-Feb-19 18954631 31-Mar-19 18906669 28-Feb-19 18877336 28-Feb-19 19037939 31-May-19 18973118 30-Apr-19 18899998 28-Feb-19 18900840 28-Feb-19 19046456 31-May-19 18972772 30-Apr-19 18955537 31-Mar-19 19005724 30-Apr-19 18935230 31-Mar-19 18925282 31-Mar-19 18876468 28-Feb-19 19032992 30-Apr-19.

Why it was recalled

Stryker Neurovascular has become aware that some units of Target Nano product do not have the intended stretch resistance. The sutures inside the coil that provide stretch resistance may have been damaged during manufacturing which can lead to an increased occurrence of coil stretching.

Root cause (FDA determination)

Process change control

Action the firm took

Stryker Neurovascular sent an Urgent Medical Device Voluntary Recall letter dated June 3, 2016, to all affected customers via FED Ex. Letter includes recall letter, list of impacted lot numbers, customer acknowledgement form and frequently asked questions. Customers were instructed to immediately check their inventory. segregate the effected inventory in a secure location for return to Stryker, circulate the Field Safety Notice internally to all interested/affected parties. Inform Stryker if any of the subject devices have been distributed to other organizations. Customers were also instructed to complete the attached customer response form and return the completed form to their nominated Stryker Representative.

Recalling firm

Firm: Stryker Neurovascular
Address: 47900 Bayside Pkwy, Fremont, California 94538-6515

Distribution

Distribution pattern: Worldwide Distribution - US (nationwide) and Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Canary Islands, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Italia, Japan,Latvia, Lebanon, Libyan Arab Jamahiriya, Lithuania, Luxembourg, Mexico,Netherlands, Norway, Peru, Philippines, Poland, Portugal, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom, United States, Uruguay, and Vietnam.

Timeline

Recall initiated: 2016-06-06
Posted by FDA: 2016-07-11
Terminated: 2017-03-03
Status: —

Source: openFDA Device Recall endpoint. Recall record ID #147582. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.